You are here

Article Text

Article menu
Download PDFPDF
Vulval Cancer
Malignant Transformation of Gartner Cyst
  1. Anne-Sophie Bats, MD*,†,
  2. Ulrike Metzger, MD*,†,
  3. Marie-Aude Le Frere-Belda, MD†,‡,
  4. Marie Brisa, MD†,§ and
  5. Fabrice Lecuru, MD*,†
  1. * Service de Chirurgie Gynécologique Cancérologique, Hôpital Européen Georges Pompidou;
  2. † Faculté de médecine, Université Paris Descartes; and
  3. ‡ Service d'Anatomo-Pathologie, and
  4. § Service de Radiologie, AP-HP, Hôpital Européen Georges Pompidou, Paris, France.
  1. Address correspondence and reprint requests to Anne-Sophie Bats, Chirurgie Gynécologique Oncologique, Hôpital Européen Georges Pompidou, 20, rue Leblanc, Paris 75015, France. E-mail: anne-sophie.bats{at}egp.aphp.fr.

Abstract

Vaginal cysts are common lesions that include Gartner cysts, which develop from the wolffian duct remnants in the vaginal wall.

Malignant transformation of Gartner cysts is exceedingly rare. Our case was diagnosed upon evaluation of vaginal bleeding in a 67-year-old woman. Histologic examination showed a clear cell carcinoma. Treatment consisted of surgical excision and radiation therapy.

Treatment quality, stage, and pelvic node status are the main prognostic factors. Regular long-term follow-up is crucial.

  • Cysts
  • Urogenital neoplasms
  • Adenocarcinoma
  • Clear cell
  • Surgery
  • Radiotherapy

https://doi.org/10.1111/IGC.0b013e3181a844f2

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.